National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

fluoxymesterone
A halogenated derivative of 17-alpha-methyltestosterone. Similar to testosterone, fluoxymesterone binds to and activates specific nuclear receptors, resulting in an increase in protein anabolism, a decrease in amino acid catabolism, and retention of nitrogen, potassium, and phosphorus. This agent also may competitively inhibit prolactin receptors and estrogen receptors, thereby inhibiting the growth of hormone-dependent tumor lines. Fluoxymesterone is approximately five times more potent than methyltestosterone. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Androfluorene
Androsterolo
US brand names:Android-F
Halodrin
Halotestin
Ora-Testryl
Ultandren
Foreign brand names:Oratestin
Stenox
Testoral
Abbreviation:FXM
Chemical structure names:
  • (11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one
  • 11Beta,17beta-dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one
  • 9Alpha-fluoro-11beta-hydroxy-17alpha-methyltestosterone



Previous:fluorine F 18 sodium fluoride, Fluorofur, Fluoroplex, fluorouracil, fluorouracil-e therapeutic implant
Next:fluphenazine hydrochloride, flurbiprofen, Flurizan, Flushield, flutamide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov